Cardiovascular Pharmacotherapy: Guidelines and Special Populations

َThis course consists of 4 parts

First Part which is "Antiplatelets in guidelines". This part was developed to deepen the learners' knowledge about the evidence-based use of antiplatelet agents in practice according to recent guidelines.

Second Part which is "Anticoagulants within guidelines". This part was developed with the aim of offering an immersive e-learning experience on anticoagulants use within recent guidelines. The goal is to enhance your understanding of anticoagulant use in atrial fibrillation, venous thromboembolism, and surgery. Finally, we are committed to equipping you with in-depth knowledge and valuable insights into the use of anticoagulants within recent guidelines.

Third Part which is "Dyslipidemia". This part was developed to provide a comprehensive overview of dyslipidemia,/ outline its etiological and epidemiological data, and discuss its main different types and symptoms.

Next, it will go over the pathophysiology of dyslipidemia, including the metabolism and regulation of lipids in the body, and also provide an in-depth review of the cardiovascular risks associated with dyslipidemia.

Fourth Part which is "Special populations". This part was developed with the primary objective of enhancing learners' understanding of hypertension management strategies in special populations. Upon completing this part, you will gain emnpower to optimize patient care and safety.